Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3698-3703

  Hung, C F ^a   Cheng, W F ^a   Hsu, K F ^a   Chai, C Y ^a   He, L ^a   Ling, M ^a   Wu, T C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CD8 ANTIGEN; DNA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PSEUDOMONAS EXOTOXIN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG POTENCY; EMBRYO; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PSEUDOMONAS AERUGINOSA; T LYMPHOCYTE ACTIVATION; TOXIN ANALYSIS; WART VIRUS;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BACTERIAL TOXINS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; EXOTOXINS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; ONCOGENE PROTEINS, VIRAL; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TRANSLOCATION, GENETIC; VACCINES, DNA; VIRULENCE FACTORS;

EID: 0035328523     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Experimental vaccine strategies for cancer immunotherapy
2. Cancer vaccines
3. Human tumor antigens for cancer vaccine development
4. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
5. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene
6. Nucleic acid malaria vaccines. Current status and potential
7. Nucleic acid vaccines: An overview
8. DNA vaccines
9. Immune recognition of foreign DNA: A cure for bioterrorism?
10. The promise of nucleic acid vaccines
11. DNA vaccines: Immunology, application, and optimization
12. DNA vaccines: A key for inducing long-term cellular immunity
13. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
14. Delivery of antigens to the MHC class I pathway using bacterial toxins
15. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli
16. Exotoxin. A of Pseudomonas aeruginosa: Evidence that domain I functions in receptor binding
17. Domain II mutants of Pseudolnonas exotoxin deficient in translocation
18. Analysis of sequences in domain II of Pseudomonas exotoxin A, which mediate translocation
19. Translocation mediated by domain II of Pseudomonas exotoxin A: Transport of barnase into the cytosol
20. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity
21. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel nonviral gene delivery system
22. A chimeric fusion protein containing transforming growth factor-α mediates gene transfer via binding to the EGF receptor
23. Immunology of the human papilloma virus in relation to cancer
24. His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP- ribosylation of elongation factor II
25. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma
26. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific antitumor immunity
27. CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes
28. Targeting HPV-16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine HPV-16 E7 expressing tumors
29. Egineering an intracellular pathway for MHC class II presentation of HPV-16 E7
30. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
31. Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein
32. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin
33. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
34. Contribution of CpG motifs to the immunogenicity of DNA vaccines
35. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
36. A Toll-like receptor recognizes bacterial DNA
37. Diphtheria toxin translocation across endosome membranes. A novel cell permeabilization assay reveals new diphtheria toxin fragments in endocytic vesicles
38. Translocation of the catalytic domain of diphtheria toxin across planar phospholipid bilayers by its own T domain
39. Channels formed in phospholipid bilayer membranes by diphtheria, tetanus, botulinum, and anthrax toxin
40. Tetanus and botulinum neurotoxins: Mechanism of action and therapeutic uses
41. Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells
42. Mechanism of membrane by anthrax toxin: Insertion and pore formation by protective antigen
43. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum
44. Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography
45. Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach
46. Production of listeriolysin by β-hemolytic strains of Listeria monocytogenes
47. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: Implication or the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells
48. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
49. "Public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes